52 results
6-K
EX-10.1
IPA
ImmunoPrecise Antibodies Ltd
23 Feb 24
Current report (foreign)
5:29pm
of Foreign Assets Control of the U.S. Department of the Treasury ("OFAC") or the U.S. Department of State, the United Nations Security Council
424B5
IPA
ImmunoPrecise Antibodies Ltd
23 Feb 24
Prospectus supplement for primary offering
5:26pm
. Department of the Treasury and the Company cannot predict how this legislation or any future changes in tax laws might affect the Company or purchasers … be no assurance that those requirements will be satisfied. The Treasury Department has released guidance temporarily pausing the application of certain
424B5
IPA
ImmunoPrecise Antibodies Ltd
7 Dec 23
Prospectus supplement for primary offering
4:53pm
, and there can be no assurance that those requirements will be satisfied. The Treasury Department has recently released guidance temporarily pausing … will be implemented by the U.S. Department of the Treasury and the Company cannot predict how this legislation or any future changes in tax laws might affect
6-K
EX-10.1
IPA
ImmunoPrecise Antibodies Ltd
6 Dec 23
Current report (foreign)
5:19pm
to any sanctions administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury ("OFAC"), the United Nations Security Council
424B5
IPA
ImmunoPrecise Antibodies Ltd
5 Dec 23
Prospectus supplement for primary offering
4:02pm
Department has recently released guidance temporarily pausing the application of certain of the Foreign Tax Credit Regulations.
Subject to the PFIC rules … such stock. It is unclear how this legislation will be implemented by the U.S. Department of the Treasury and the Company cannot predict how
6-K
EX-10.1
ubebvdgmdudw
15 Aug 23
Current report (foreign)
5:50pm
424B5
9t1uf 32fi
15 Aug 23
Prospectus supplement for primary offering
5:47pm
F-3
wdrd 1uuusbkm0r
10 Jul 23
Shelf registration (foreign)
7:04pm
40-F
EX-99.1
19gi0wralvqb01 ckdo
10 Jul 23
Annual report (Canada)
4:32pm
6-K
EX-99.1
hie1ozq 9xw
24 Apr 23
Current report (foreign)
10:01am
40-F
EX-99.2
cd3 9hgkwbk8w
29 Jul 22
Annual report (Canada)
9:04am
40-F
EX-99.1
f6tbf869xs 3sn1
29 Jul 22
Annual report (Canada)
9:04am
6-K
EX-99.1
lv2gg12 fi
29 Jul 22
Immunoprecise Antibodies LTD. 6-K
8:17am
6-K
EX-99.2
m3ayyj7xpiatuwu46dt
14 Apr 22
Current report (foreign)
10:18am
6-K
EX-99.1
c2593u2d4on nhnw34v
16 Mar 22
Immunoprecise Antibodies LTD. 6-K
8:02am
6-K
EX-99.2
iix9q2cfx95lto
16 Mar 22
FY22 Q3 6-K
8:00am
6-K
EX-99.1
9ehdjg0x
14 Mar 22
Immunoprecise Antibodies LTD. 6-K
9:35am
6-K
EX-99.2
ueg 38q0xp2puv
13 Dec 21
Ipa FY22 Q2 6-K
8:57am
6-K
EX-99.2
2jc2h1s3 zxv4q
13 Oct 21
ImmunoPrecise Announces At-The-Market Facility of up to US$50 Million
5:31pm
SUPPL
rkte5i9l
13 Oct 21
Supplemental materials (foreign)
5:29pm